PNT - Point Biopharma Global Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PNT (1811764)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-12-18
PNTBvf Partners L P/IlFormer 10% OwnerS - Sale$12.45-17,161,2780-100%-$213,657,911
2022-11-29
PNTMcCann Joe A.CEOP - Purchase$6.64+2,1603,616,3130%+$14,342
2022-11-23
PNTLubner David CharlesDirP - Purchase$6.85+3,6003,600New+$24,660
2022-11-25
PNTHogue Gerald L.DirP - Purchase$6.82+3,6603,660New+$24,943
2022-11-28
PNTMalik RajeshDirP - Purchase$6.66+3,7003,700New+$24,642
2022-11-21
PNTMargolin YaelDirP - Purchase$6.56+1,7101,710New+$11,218
2022-11-18
PNTGoodman Jonathan R.DirP - Purchase$6.33+6,00041,872+17%+$37,980
M
2022-11-17
PNTSilber Allan CExec COB, 10%P - Purchase$6.22+50,0009,227,975+1%+$311,199

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top